世卫报告：中国每四个成年人就有一名高血压患者

Core Viewpoint - The World Health Organization (WHO) report indicates that in 2024, the hypertension prevalence among Chinese adults aged 30-79 is 29%, which is lower than the global average, but still represents approximately 271.5 million individuals suffering from hypertension in China. The control rate of hypertension in China is only 18%, significantly below the WHO's target of 50% [1][3][7]. Group 1: Hypertension Prevalence and Control - In 2024, approximately 29% of Chinese adults aged 30-79 are affected by hypertension, equating to about 271.5 million individuals [1][7]. - The control rate of hypertension in China is only 18%, with over 40% of patients unaware of their condition and more than 50% not receiving treatment [1][3][7]. - Globally, only slightly over 20% of hypertension patients are effectively controlled through medication or health interventions [4]. Group 2: Global Context and Economic Impact - Hypertension is a leading cause of heart disease, stroke, chronic kidney disease, and dementia, with an estimated economic loss of $3.7 trillion in low- and middle-income countries from 2011 to 2025 due to cardiovascular diseases, including hypertension [3][4]. - The WHO estimates that if no action is taken, the number of global hypertension patients could exceed 1.5 billion by 2030, but improving control rates to 50% could prevent 76 million deaths by 2050 and save hundreds of billions in healthcare costs annually [3][4]. Group 3: Treatment and Policy Recommendations - The WHO emphasizes the importance of antihypertensive medications as one of the most cost-effective public health tools, recommending the use of combination therapies [5][6]. - There is a significant disparity in the availability of recommended medications between low-income and high-income countries, with only 28% of low-income countries reporting universal access to WHO-recommended drugs [6]. - The report calls for improved drug regulatory systems, pricing and payment systems, and supply chain management to enhance access to hypertension medications [6]. Group 4: China's Initiatives and Recognition - China's experience in hypertension management has been recognized by the WHO, particularly its focus on community-based strategies and effective policies for cardiovascular disease prevention [2][7]. - Recent projects in rural areas, such as the "Hypertension Control Promotion" initiative in Changtu County, have shown promising results, with over 5,000 patients actively receiving treatment and a significant percentage achieving controlled blood pressure [8]. - The Chinese government aims to increase the hypertension control rate to over 70% by 2030, with ongoing efforts to enhance medication accessibility and management services for hypertension patients [9].